Palatin Technologies
PTN
#10062
Rank
C$36.61 M
Marketcap
C$21.50
Share price
-2.06%
Change (1 day)
1,328.95%
Change (1 year)

P/E ratio for Palatin Technologies (PTN)

P/E ratio as of February 2026 (TTM): -0.5232

According to Palatin Technologies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.523244. At the end of 2022 the company had a P/E ratio of -0.0186.

P/E ratio history for Palatin Technologies from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2022-0.0186-73.28%
2021-0.0697-43.65%
2020-0.1236
2014-1.46

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
22.9-4,486.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
36.1-6,998.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
32.9-6,384.64%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-6.52 1,146.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
80.5-15,482.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
47.3-9,130.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-0.3019-42.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-31.6 5,936.76%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.